Todd A. Huffman
Analyst
Huffman assists in the scientific and business analysis of early-stage biomedical investment opportunities for RCT's Therapeutics Group. He has a strong background in biomedical science with expertise in pharmacology and physiology, along with experience in deal making and technology valuation. His areas of focus include diabetes, oncology, pain and CNS disorders.
Professional Experience
Research Corporation Technologies
Analyst, Commercialization, 2007-present
University of North Carolina at Chapel Hill
Technology Development Associate, 2007
University of Virginia Patent Foundation, Charlottesville
Licensing Associate, 2005-2007
Education
University of Virginia
Ph.D., Molecular Pharmacology, 2005
Virginia Polytechnic Institute and State University, Blacksburg
B.S., Biochemistry, 1998